These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 12383565
1. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F, HALT-MI Investigators. J Am Coll Cardiol; 2002 Oct 02; 40(7):1199-204. PubMed ID: 12383565 [Abstract] [Full Text] [Related]
2. An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). Rusnak JM, Kopecky SL, Clements IP, Gibbons RJ, Holland AE, Peterman HS, Martin JS, Saoud JB, Feldman RL, Breisblatt WM, Simons M, Gessler CJ, Yu AS. Am J Cardiol; 2001 Sep 01; 88(5):482-7. PubMed ID: 11524054 [Abstract] [Full Text] [Related]
8. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. Kopecky SL, Aviles RJ, Bell MR, Lobl JK, Tipping D, Frommell G, Ramsey K, Holland AE, Midei M, Jain A, Kellett M, Gibbons RJ, AmP579 Delivery for Myocardial Infarction REduction study. Am Heart J; 2003 Jul 01; 146(1):146-52. PubMed ID: 12851624 [Abstract] [Full Text] [Related]
9. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. JACC Cardiovasc Imaging; 2010 Jan 01; 3(1):52-60. PubMed ID: 20129531 [Abstract] [Full Text] [Related]
10. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy. Sciagrà R, Parodi G, Migliorini A, Valenti R, Antoniucci D, Sotgia B, Pupi A. Am J Cardiol; 2006 Jan 01; 97(1):48-54. PubMed ID: 16377283 [Abstract] [Full Text] [Related]
16. Aspiration coronary thrombectomy for acute myocardial infarction increases myocardial salvage: single center randomized study. Ciszewski M, Pregowski J, Teresińska A, Karcz M, Kalińczuk Ł, Pracon R, Witkowski A, Rużyłło W. Catheter Cardiovasc Interv; 2011 Oct 01; 78(4):523-31. PubMed ID: 21234920 [Abstract] [Full Text] [Related]
17. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. Zohlnhöfer D, Ott I, Mehilli J, Schömig K, Michalk F, Ibrahim T, Meisetschläger G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schömig A, REVIVAL-2 Investigators. JAMA; 2006 Mar 01; 295(9):1003-10. PubMed ID: 16507801 [Abstract] [Full Text] [Related]
19. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty. Clements IP, Christian TF, Higano ST, Gibbons RJ, Gersh BJ. Circulation; 1993 Oct 01; 88(4 Pt 1):1527-33. PubMed ID: 8403301 [Abstract] [Full Text] [Related]
20. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Am Heart J; 2004 Aug 01; 148(2):336-40. PubMed ID: 15309006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]